Imagion Biosystems has released Appendix 3B: New issue announcement, application for quotation of additional securities and agreement.
Read Appendix 3B.
Dr. Nina Webster Joins IBX Board of Directors
September 1, 2025
Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilizing its proprietary MagSense® imaging